Tivic Health Systems, Inc. (TIVC)
| Previous Close | 0.4599 |
| Open | 0.4558 |
| Bid | 0.4368 x 200 |
| Ask | 0.4632 x 200 |
| Day's Range | 0.4352 - 0.4600 |
| 52 Week Range | 0.4352 - 21.8000 |
| Volume | |
| Avg. Volume | 734,856 |
| Market Cap | 2.783M |
| Beta (5Y Monthly) | 2.83 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Tivic Health Partners with the Feinstein Institutes to Advance its Patent-pending, Non-Invasive Cervical Vagus Nerve Stimulation; Begins Optimization of ncVNS for use in Clinical Indications
SAN FRANCISCO, May 22, 2024--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today it has initiated the second phase of its clinical work to advance its novel non-invasive cervical vagus nerve stimulation ("ncVNS"). The company has entered into a collaboration agreement with The Feinstein Institutes for Medical Research at Northwell Health to optimize its ncVNS device therapy for use in specific
- Business Wire
Tivic Reports First Quarter 2024 Financial Results and Subsequent Events
SAN FRANCISCO, May 15, 2024--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its first quarter 2024 financial results with discussion of subsequent events.
- Business Wire
Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast
SAN FRANCISCO, May 13, 2024--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will report its Q1 2024 financial results via pre-recorded conference call and webcast on Wednesday, May 15th at 1:30 PM PT / 4:30 PM ET.
